Tricuspid stenosis

Article written and reviewed by Dr Luca Moretti

Tricuspid stenosis is obstruction of diastolic flow from the right atrium to the right ventricle and is a rare valvular heart disease. Most acquired cases are rheumatic and coexist with mitral stenosis; when stenosis is isolated, carcinoid disease, congenital abnormalities, masses, devices, or prosthetic valve dysfunction should be sought. Its rarity does not diminish its clinical importance because the obstruction may be masked by dominant left-sided valve disease and become apparent only after that lesion is corrected.

The normal tricuspid valve provides a large area for low-pressure flow. When the orifice narrows, a small mean gradient may represent important obstruction, but it remains strongly dependent on heart rate and flow. Tachycardia, anemia, pregnancy, and regurgitation increase flow and the gradient; low output and advanced heart failure can reduce it. Diagnosis therefore cannot be equated with an isolated Doppler threshold.

Increased atrial pressure is transmitted to the venae cavae, liver, and systemic venous circulation, causing congestion even with normal pulmonary pressure. Flow through the right heart may decrease and limit left-sided filling, producing fatigue and hypotension. Associated tricuspid regurgitation modifies signs, gradients, and strategy; stenosis and regurgitation must be quantified separately.

Etiology and pathological anatomy

In rheumatic heart disease, valvular inflammation heals with fibrosis, commissural fusion, leaflet thickening and retraction, and chordal shortening. The orifice becomes narrowed and opening becomes doming. Clinically significant tricuspid involvement is almost never the only manifestation: the mitral valve is generally diseased, and aortic lesions may coexist. A history of rheumatic fever may be absent.

In carcinoid heart disease, the right-sided endocardium is exposed to serotonin and other mediators, especially in the presence of hepatic metastases or a source that bypasses pulmonary and hepatic metabolism. Fibrous plaques form over the leaflets, chordae, and wall, retract tissue, and fix the valve in a semi-open position, more often producing severe regurgitation associated with a variable stenotic component and frequent pulmonary valve involvement.

Congenital causes include dysplasia, incomplete atresia, a small annulus, and abnormalities of the subvalvular apparatus. Ebstein anomaly mainly produces regurgitation through apical displacement of the leaflets, but dysplastic tissue or previous repairs may create obstruction. In survivors of complex congenital heart disease, conduits, patches, and multiple operations make stenosis an individualized anatomical disease that cannot be classified solely by acquired-disease criteria.

Large vegetations, thrombi, right atrial myxoma, and metastases can dynamically obstruct the orifice. A lead or multiple leads can adhere to the apparatus, promote fibrosis, and reduce opening; device-related obstruction is distinct from the more common device-related tricuspid regurgitation. A mechanical cause must be demonstrated because extraction of a chronic lead carries its own risks.

Serotonergic drugs and ergot derivatives can induce plaques and retraction similar to carcinoid disease, often with multivalvular involvement. Lupus, antiphospholipid syndrome, Libman-Sacks endocarditis, radiotherapy, and infiltrative diseases are exceptional causes. Native calcific tricuspid stenosis is extraordinarily rare; calcium and fibrosis are more plausible after repair or in the setting of a degenerated prosthesis.

A bioprosthesis may become stenotic because of structural degeneration, thrombosis, pannus, or endocarditis; an undersized surgical ring can cause functional stenosis. Time from implantation, increase in gradient, and leaflet appearance distinguish the mechanisms. Mechanical prostheses in the right-sided position are particularly prone to thrombosis because of low flow velocity and require urgent assessment when the gradient rises.

Etiologic distinction also guides extracardiac therapy: all valves must be assessed in rheumatic disease; tumor burden and hormone secretion must be controlled in carcinoid disease; sterilization and pulmonary embolic risk influence timing in endocarditis; and in prosthetic thrombosis the choice among anticoagulation, fibrinolysis, and surgery depends on stability and anatomy. The term stenosis therefore describes the hemodynamics but does not exhaust treatment of the disease that produced it.

The history should reconstruct geographic origin and rheumatic prophylaxis, carcinoid syndrome, anorectic or dopaminergic drugs, congenital heart disease, endocarditis, transplantation, radiotherapy, valve procedures, and anticoagulation. Blood cultures, inflammatory markers, 5-HIAA, natriuretic peptides, and oncologic imaging are not requested indiscriminately but according to phenotype. In a prosthesis, comparison with the baseline echocardiogram, antithrombotic adherence, and time since implantation are often more informative than a single gradient.

Pathophysiology and clinical manifestations

As valve area decreases, an increasing diastolic gradient is required to maintain flow, and the right atrium responds with dilation, hypertrophy, and increased mean pressure. Flow into the ventricle thus becomes increasingly dependent on atrial contraction, so atrial fibrillation and tachycardia, by removing the late-diastolic contribution and shortening filling time, can rapidly worsen output and congestion.

The obstruction limits the increase in cardiac output during exercise. Patients may describe fatigue, weakness, and reduced endurance rather than dyspnea, particularly in the absence of pulmonary or left-sided valvular disease. When mitral stenosis coexists, reduced right-sided output may attenuate pulmonary congestion and make the mitral lesion appear less severe; after mitral commissurotomy, increased flow may unmask tricuspid stenosis.

Elevated venous pressure causes jugular venous distension with a prominent a wave in sinus rhythm and a slow y descent, hepatomegaly, ascites, peripheral edema, and early satiety. If important regurgitation is present, the v wave becomes dominant and findings overlap. The skin may show flushing and telangiectasias in carcinoid disease, but absence of these signs does not exclude cardiac involvement.

Auscultation may reveal a low-frequency diastolic rumble along the lower sternal border, accentuated by inspiration and maneuvers that increase venous return; an opening snap may also occur in rheumatic disease. The murmur, however, may be soft when output is reduced or the valve is very rigid, so an apparently normal examination does not exclude significant stenosis documented by imaging.

Chronic congestion leads to congestive hepatopathy, cholestasis, reduced albumin, protein-losing enteropathy, and worsening renal function. Creatinine and transaminases may remain nearly normal until advanced stages; bilirubin, INR, sodium, platelet count, and diuretic response help define reserve. Ascites should not automatically be attributed to primary cirrhosis in a patient with elevated jugular venous pressure.

Atrial fibrillation or flutter is promoted by atrial dilation. Stasis in the right atrium may produce thrombi, especially in the presence of catheters, malignancy, or prostheses, although pulmonary embolism from right atrial thrombus is less characteristic than systemic embolism in mitral stenosis. A right-to-left interatrial shunt can cause cyanosis and paradoxical embolism when right atrial pressure exceeds left atrial pressure.

The prognosis of isolated stenosis is poorly defined because of its rarity. In associated forms, outcome depends on left-sided valve disease, the right ventricle, kidneys, liver, and the causal disease. A moderate lesion overlooked during rheumatic surgery may progress or become symptomatic when flow increases; a late isolated reoperation carries greater risk than planned concomitant correction.

Pregnancy, infection, anemia, and hyperthyroidism can decompensate previously tolerated obstruction by increasing heart rate and flow. During pregnancy congestion may progress even without a large resting gradient; preconception planning assesses severity, right ventricular function, and associated lesions. Physical activity is not automatically restricted in mild disease, but syncope, cyanosis, arrhythmias, or inability to increase output require specialist assessment and, in uncertain cases, exercise testing with observation of symptoms and blood pressure response.

Echocardiography and hemodynamic confirmation

Transthoracic echocardiography is the first-line examination. Dedicated apical four-chamber, parasternal short-axis, and subcostal views assess thickening, mobility, doming, commissural fusion, chordae, vegetations, and masses. Color Doppler shows diastolic acceleration and the orifice; 3D imaging may visualize the atrial surface and locate restriction, although shadowing and limited resolution constrain planimetry.

Continuous-wave Doppler is aligned with tricuspid inflow and recorded over multiple cycles. In sinus rhythm, the mean gradient is measured while avoiding post-extrasystolic beats; in atrial fibrillation, cycles with comparable intervals are averaged. Respiration changes flow and velocity: the report should state the method and heart rate because a value obtained during tachycardia cannot be compared directly with one obtained after rate control.

Findings conventionally compatible with significant stenosis include a mean gradient of at least 5 mmHg at a normal heart rate, diastolic flow velocity-time integral greater than 60 cm, pressure half-time of at least 190 ms, and calculated valve area no greater than approximately 1 cm². These are orienting thresholds derived from limited evidence. Regurgitation, atrial and ventricular compliance, ventilation, and flow alter every measurement.

Pressure half-time uses the relationship valve area equals 190 divided by PHT, but the constant has not been validated with the robustness of the mitral equation. A stiff ventricle accelerates decay and overestimates area; a poorly compliant atrium prolongs it. The continuity equation requires a reliable stroke volume and fails with multiple regurgitant lesions or shunts. 3D planimetry is promising but depends on selecting the correct orifice plane.

Assessment should include tricuspid regurgitation, the atrium, vena cava, hepatic vein flow, right ventricular size and function, pulmonary pressure, and all valves. Important stenosis is associated with atrial dilation and prolonged diastolic flow; a nondilated right ventricle does not exclude obstruction. Severe associated regurgitation may increase the gradient by increasing forward flow.

Transesophageal echocardiography clarifies vegetations, thrombi, prostheses, and anatomy when transthoracic imaging is incomplete, although the anterior position of the tricuspid valve may make some views less favorable. CT defines calcium, masses, leads, and prostheses; magnetic resonance measures volumes and flow but is not the main method for low gradients. In carcinoid disease, imaging simultaneously evaluates the pulmonary valve and right-sided consequences.

Right-heart catheterization is reserved for clinical-echocardiographic discordance, suspected pulmonary hypertension that cannot be quantified, and complex planning. Right atrial and ventricular pressures should be recorded simultaneously with calibrated transducers; the mean diastolic gradient is influenced by respiration. Catheters crossing a small orifice can introduce a gradient, and sedation may reduce flow.

When symptoms and resting measurements disagree, exercise testing may document an inability to increase cardiac output, disproportionate tachycardia, or emergence of congestion; however, stress thresholds are not as well validated as those for left-sided stenotic lesions. Invasive measurements must be interpreted together with cardiac output and heart rate because the same gradient can represent different degrees of obstruction. If mitral stenosis coexists, treating it may suddenly increase tricuspid flow: right-sided severity must be defined before, not after, the left-sided intervention.

The differential diagnosis includes constrictive pericarditis, restrictive cardiomyopathy, vena cava obstruction, atrial tumor, tamponade, and severe tricuspid regurgitation. A large a wave and a Doppler gradient support valvular obstruction, but pericardial and myocardial disease can coexist. The clinical picture should be reconstructed without forcing a single echocardiographic abnormality to explain all congestion.

Medical and interventional treatment

Diuretics reduce edema and ascites, while moderate sodium restriction and weight monitoring assist management. Excessive reduction in preload can worsen low output across the fixed orifice. Rate control in atrial fibrillation prolongs diastole; rhythm restoration may be useful when realistic, but atrial dilation and valvular disease reduce its durability.

Treatment of the cause is essential. In carcinoid disease, somatostatin analogues, oncologic therapy, and control of perioperative carcinoid crisis are coordinated by a neuroendocrine team; reducing mediator levels does not reverse established fibrosis. Endocarditis requires targeted antibiotics and source control. In prosthetic thrombosis, anticoagulation or urgent treatment follows prosthesis type, thrombus size, and clinical stability.

Intervention is indicated for symptomatic severe stenosis and is performed concomitantly when severe stenosis accompanies surgery on other valves. The decision should precede irreversible hepatic, renal, and ventricular damage. Symptoms, gradient, area, functional capacity, cause, and risk are integrated; an anatomical threshold without consequences does not automatically mandate a prosthesis.

Surgical commissurotomy may separate rheumatically fused commissures when leaflet mobility is still preserved; repair and annuloplasty address selected deformities. If tissue is severely fibrotic, affected by carcinoid disease, calcified, or destroyed, replacement is more reliable. A bioprosthesis is often preferred to reduce thrombotic risk in the right-sided position, but durability and the possibility of future valve-in-valve treatment should be discussed.

Percutaneous balloon valvuloplasty has been used in rare cases of isolated rheumatic stenosis or stenosis associated with mitral disease amenable to percutaneous treatment. Favorable anatomy requires commissural fusion, limited calcification, a subvalvular apparatus that is not severely retracted, and no more than mild regurgitation. The balloon can tear a leaflet and convert obstruction into severe regurgitation; experience is far more limited than with mitral commissurotomy.

In a degenerated bioprosthesis, transcatheter valve-in-valve treatment can address stenosis or regurgitation in selected high-risk patients. CT and fluoroscopy define internal diameter, risk of malposition, and relationship with leads. A stenotic native valve without a surgical ring does not provide the same anchoring and should not be treated as equivalent to valve-in-valve anatomy.

The surgical strategy also includes management of the conduction system and venous access. Deep sutures near the triangle of Koch can cause atrioventricular block; a lead crossing a new prosthesis may interfere with the leaflets and complicate future procedures. In patients requiring pacing, epicardial, coronary venous, or leadless options are considered according to anatomy and risk. Sizing should avoid an undersized prosthesis: a high residual gradient in a low-flow position reduces the benefit of intervention and may make future valve-in-valve treatment difficult.

Carcinoid surgery requires timing relative to tumor control. Severe valve damage with symptoms or progressive remodeling may justify intervention even in the presence of oncologic disease if expected survival allows benefit. Anesthesia and cardiopulmonary bypass can trigger mediator release; octreotide, hemodynamic management, and right ventricular protection are planned in advance.

Follow-up and prognosis after treatment

Mild or moderate stenosis is followed with history, examination, ECG, and echocardiography at intervals proportionate to severity. Follow-up records heart rate, gradient, valve area, regurgitation, atrial size, right ventricular status, and congested organs. An increase in gradient may reflect tachycardia or anemia and should be confirmed under comparable conditions before progression is declared.

The development of ascites, increasing diuretic requirements, flutter or fibrillation, reduced functional capacity, or hepatorenal abnormalities requires earlier reassessment. Other valves are monitored in rheumatic disease; biomarkers and oncologic imaging are added in carcinoid disease; thrombosis or degeneration is sought in prosthetic valves. Follow-up is therefore etiologic as well as hemodynamic.

After commissurotomy or repair, a baseline echocardiogram is obtained to document residual gradient and regurgitation. Restenosis may result from refusion, progressive fibrosis, or a small annulus; new regurgitation indicates commissural injury or failed coaptation. Comparison with the postprocedural study distinguishes an incomplete procedure from late deterioration.

After replacement, gradients, leaflet motion, leak, thrombosis, endocarditis, and right ventricular function are assessed. A rising gradient is interpreted together with heart rate, flow, and prosthesis size; CT may show leaflet thickening or reduced motion. Anticoagulation depends on prosthesis type, rhythm, and bleeding risk, with adherence particularly important in the tricuspid position.

Recovery from congestion may be slow if the liver, kidneys, and lymphatic system have been exposed to elevated pressures for years. Normalization of the gradient does not guarantee normal functional capacity when mitral stenosis, pulmonary hypertension, or right ventricular dysfunction coexist. Realistic goals include lower diuretic requirements, less ascites, and greater activity, in addition to survival.

New early dyspnea after a procedure requires distinction among residual stenosis, iatrogenic regurgitation, right ventricular dysfunction, tamponade, and pulmonary disease. During late follow-up, a parallel increase in gradient and leaflet thickness suggests thrombosis or degeneration; a high but stable gradient from baseline instead points toward mismatch or high flow. This distinction avoids treating an undersized prosthesis as thrombosis and, conversely, avoids waiting in the presence of potentially reversible loss of leaflet motion.

Prevention of rheumatic recurrence with secondary prophylaxis follows age, exposure, and local guidelines; oral hygiene and endocarditis prophylaxis apply to high-risk categories, especially after prosthetic valve replacement. No drugs can reopen fibrotic commissures or dissolve carcinoid plaques. Competent surveillance is intended to recognize the window in which correction remains effective and organ risk is still reversible.